AbbVie (ABBV) Assets Average (2013 - 2026)

AbbVie (ABBV) has 14 years of Assets Average data on file, last reported at $135.2 billion in Q1 2026.

• Quarterly Assets Average changed 0.33% year-over-year to $135.2 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $135.2 billion (changed 0.33% YoY) and the FY2025 annual result came in at $134.6 billion, changed 0.28% from the prior year.
• Assets Average advanced to $135.2 billion in Q1 2026 per ABBV's latest filing, from $133.9 billion in the prior quarter.
• Across five years, Assets Average topped out at $145.4 billion in Q2 2024 and bottomed at $133.9 billion in Q4 2025.
• The 5-year median for Assets Average is $136.7 billion (2023), against an average of $138.8 billion.
• The widest annual swing landed in 2024, when Assets Average increased 7.74%; it then retreated 6.01% in 2025.
• Tracing ABBV's Assets Average over 5 years: stood at $140.1 billion in 2022, then decreased by 3.28% to $135.5 billion in 2023, then gained by 2.82% to $139.3 billion in 2024, then slipped by 3.85% to $133.9 billion in 2025, then advanced by 0.96% to $135.2 billion in 2026.
• Per Business Quant, the three latest ABBV Assets Average figures stand at $135.2 billion (Q1 2026), $133.9 billion (Q4 2025), and $135.5 billion (Q3 2025).

Peer Comparison